For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...

As blockbuster GLP-1 injectables like Mounjaro, Wegovy and Ozempic gain traction in India, doctors stress that careful ...

Over half a million Californians could lose access to the hugely popular GLP-1 weight loss drugs starting Jan. 1, 2026, after ...

The GLP-1, which she typically injects weekly (she declines to share which specific brand of medication she uses) has been ...

At the end of the day, GLP-1s can be a powerful tool for achieving your weight loss goals, but only if they're safe and ...

Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

People have been losing weight on retatrutide, more powerful than GLP-1 agonist drugs, but they are buying them from ...

Shake Shack's Good Fit Menu puts a high-protein and gluten-free spin on the classics that are made with customers using GLP-1 ...

Despite the definitive failure of Novo Nordisk’s semaglutide in Alzheimer’s, biotech executives, analysts and other industry ...

Oprah Winfrey says realizing obesity — not overeating — was the root issue changed her relationship with food, exercise and ...

GLP-1 users are spending less on food, from grocery stores to restaurants, according to a study published in the 'Journal of ...